Background Circle Background Circle
FDA approves first drug for serious liver disease

FDA approves first drug for serious liver disease

The U.S. Food and Drug Administration (FDA) has approved the first drug to treat serious liver disease, the agency announced in a release Thursday. The FDA approved Rezdiffra (resmetirom) for the treatment of adults with a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH. NASH, also known as metabolic dysfunction-associated steatohepatitis, or MASH, […]

FDA approves first cellular therapy to treat advanced melanoma

FDA approves first cellular therapy to treat advanced melanoma

The Food and Drug Administration (FDA) announced Friday that it approved a ground breaking cellular therapy treatment for patients with advanced melanoma, and surgery has been unsuccessful. Amtagvi, a type of T-cell therapy, involves boosting immune cells within tumor tissue to help the body fight off the cancer. During the treatment, the patient’s t-cells are […]

FDA approves first treatment for severe frostbite

FDA approves first treatment for severe frostbite

(NewsNation) — The Food and Drug Administration (FDA) has approved the first-ever treatment option for frostbite in adults. The agency approved the Aurlumyn injection, which can help reduce the risk of finger or toe amputation, on Wednesday. “Having this new option provides physicians with a tool that will help prevent the life-changing amputation of one’s […]

FDA approves first ever DNA test to help screen for risk of opioid use disorder

FDA approves first ever DNA test to help screen for risk of opioid use disorder

The first-ever DNA test to help determine if someone has a greater risk of developing opioid use disorder was approved by the Food and Drug Administration (FDA) this week. The FDA approved the AutoGenomics AvertD test for use among adults who are considering treating acute pain with short-term prescription of opioid pain medicine, such as after […]

FDA approves first use of CRISPR gene editing to treat sickle cell disease

FDA approves first use of CRISPR gene editing to treat sickle cell disease

The Food and Drug Administration (FDA) on Friday approved a new therapy for treating sickle cell disease, with this move also marking the first instance of CRISPR gene editing receiving approval from federal regulators. The FDA approved two new treatments for sickle cell disease (SCD) on Friday, Casgevy and Lyfgenia. Casgevy, also known as exa-cel, […]

FDA approves first vaccine for mosquito-born viral disease

FDA approves first vaccine for mosquito-born viral disease

The Food and Drug Adminstration (FDA) approved the first vaccine for the mosquito-born illness chikungunya on Thursday, a key step in fighting the dangerous virus. Chikungunya virus infects more than 300,000 people per year globally, the FDA said, mostly in the global south. The virus has recently become more prevalent in the north, however, leading […]

FDA approves blockbuster Eli Lilly drug for weight loss

FDA approves blockbuster Eli Lilly drug for weight loss

The Food and Drug Administration (FDA) approved Eli Lilly’s blockbuster diabetes drug for weight loss management Wednesday, giving patients another tool and opening the door to potentially much wider use.  Formal FDA approval means tirzepatide could be covered by most insurance plans, making it more affordable for millions of patients and likely adding to the […]

FDA approves generic versions of ADHD drug Vyvanse

FDA approves generic versions of ADHD drug Vyvanse

The Food and Drug Administration (FDA) approved the first generic versions of Vyvanse, a drug used to treat attention deficit/hyperactivity disorder (ADHD), a decision that comes amid a nationwide shortage of ADHD treatment drugs.  The newly approved medication can treat both ADHD in patients six years and older and binge-eating disorder in adults, the FDA […]